Batavia Biosciences process development viral vector-based Nipah vaccine
Batavia Biosciences partners with the University of Tokyo to develop a vector-based vaccine against Nipah virus
14. Mai 2019 07:00 ET | Batavia Biosciences B.V.
Leiden, the Netherlands, May 14, 2019 – Batavia Biosciences announced today that it will work together in a consortium including the European Vaccine Initiative and Stanford University, icddr,b, and...
The Henry M. Jackson
The Henry M. Jackson Foundation Licenses Nipah Virus and Hendra Virus Vaccine for the Development of a Human Vaccine Bethesda, MD, May 24, 2018 (GLOBE NEWSWIRE) -- The Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) today announced a license agreement of the vaccine for Nipah virus and...